Original Articles
Vol. 1 No. 2 (2025)
Prevalence of hepatitis B virus among pregnant women in the southern district of N’Djamena and strategies to prevent mother-to-child transmission
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 3 October 2025
601
Views
250
Downloads
Authors
Hepatitis B remains a major public health concern in Sub-Saharan Africa, with a high risk of mother-to-child transmission. The objective of this study was to estimate the prevalence of hepatitis B surface antigen (HBsAg) among pregnant women in the southern district of N’Djamena and to document neonatal vaccination coverage within 24 hours. A descriptive cross-sectional study was conducted in five health facilities from December 2023 to December 2024. HBsAg screening was performed using an immunochromatographic test (manufacturer’s standard procedure) and confirmed in the laboratory. Among 4,876 participants, 520 were HBsAg-positive (prevalence: 10.66%), with a mean age of 25.17 years, and 35.37% of the participants were illiterate. Out of 289 births from HBsAg+ mothers, 77.85% (n=225) of newborns received the vaccine dose within 24 hours. Inter-facility variations were observed. The observed prevalence confirms high endemicity in the southern district of N’Djamena, as well as a high acceptance of the vaccine at birth. These preliminary results support the implementation of an integrated policy: systematic screening during pregnancy, universal birth-dose vaccination, and community awareness campaigns.
Downloads
Download data is not yet available.
Citations
Trépo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet 2014;384:2053‑63. DOI: https://doi.org/10.1016/S0140-6736(14)60220-8
World Health Organization. Global hepatitis report, 2017. WHO; 2017. Available from: https://www.who.int/publications/i/item/9789241565455
Ranger-Rogez S, Alain S, Denis F. Virus des hépatites: transmission mère-enfant [Hepatitis viruses: mother-to-child transmission]. Pathologie Biologie 2002;50:568‑75. DOI: https://doi.org/10.1016/S0369-8114(02)00351-6
Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54:1-31. Erratum in: MMWR Morb Mortal Wkly Rep 2006;55:158-9. Erratum in: MMWR Morb Mortal Wkly Rep 2007;56:1267.
World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine 2019;37:223-5. DOI: https://doi.org/10.1016/j.vaccine.2017.07.046
World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. WHO; 2021.
Available from: https://www.who.int/publications/i/item/9789240027077
Habkreo M, Moussa AM, Saleh TM, et al. Prevalence of Viral Hepatitis B Among Pregnant Women in N’Djamena. Am J Health Res 2022;10:175‑8.
Debsikréo N, Mankréo BL, Moukenet A. Prevalence of Hepatitis B and Associated Factors among Pregnant Women in N’Djamena, Chad. Fortune J Health Sci 2023;6:253-62. DOI: https://doi.org/10.21203/rs.3.rs-2522118/v1
Debsikréo N, Mankréo BL, Moukénet A, et al. Prevalence of hepatitis B virus infection and its associated factors among students in N’Djamena, Chad. PLoS One 2024;19:e0273589. DOI: https://doi.org/10.1371/journal.pone.0273589
Nguwoh SP, Fokam J, Taheu CN, et al. Associated risk factors with seroprevalence of HIV and HBV co-infection among pregnant women attending Guelendeng Health District in the Mayo-Kebbi East Region of Chad. Int J Preg Childbirth 2020;6:155‑60. DOI: https://doi.org/10.15406/ipcb.2020.06.00215
Alassan KS, Imorou RS, Sonombiti H, et al. Séroprévalence et facteurs associés à l’hépatite virale B chez les gestantes à Parakou en République du Bénin [Seroprevalence and factors associated with viral hepatitis B among pregnant women in Parakou, Republic of Benin]. Pan Afr Med J 2019;33:226. DOI: https://doi.org/10.11604/pamj.2019.33.226.19429
Mawouma ARN, Djoulatou AH, Komnang EO, Kimessoukie EO. Facteurs associés à l’infection de l’hépatite B chez les femmes enceintes dans les formations sanitaires du district de santé de Mokolo/Région de l’Extrême-Nord Cameroun [Factors associated with hepatitis B infection in pregnant women at health facilities in the health district of Mokolo/Far North of Cameroon]. Pan Afr Med J 2022;41:61.
Mvumbi GM, Keïta BD, Camara N, et al. Prévalence et facteurs associés aux hépatites B et C chez les travailleuses du sexe de Bamako, Mali [Prevalence and factors associated with hepatitis B and C among female sex workers in Bamako, Mali]. Pan Afr Med J 2024;49:118. DOI: https://doi.org/10.11604/pamj.2024.49.118.39119
Fessehaye N, Berhane A, Ahmed H, et al. Prevalence of Hepatitis B Virus Infection and Associated Seromarkers among Pregnant Women in Eritrea. J Hum Virol Retrovirol 2018;6:1-6.
Kishk R, Mandour M, Elprince M, et al. Pattern and interpretation of hepatitis B virus markers among pregnant women in Northeast Egypt. Braz J Microbiol 2020;51:593‑600. DOI: https://doi.org/10.1007/s42770-019-00174-3
Bancha B, Kinfe AA, Chanko KP, et al. Prevalence of hepatitis B viruses and associated factors among pregnant women attending antenatal clinics in public hospitals of Wolaita Zone, South Ethiopia. Plos One 2020;15:e0232653. DOI: https://doi.org/10.1371/journal.pone.0232653
Fomulu NJ, Morfaw FL, Torimiro JN, et al. Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth 2013;13:158. DOI: https://doi.org/10.1186/1471-2393-13-158
Wondmeneh TG, Mekonnen AT. Epidemiology of hepatitis B virus infection among pregnant women in Africa: a systematic review and meta-analysis. BMC Infect Dis 2024;24:921. DOI: https://doi.org/10.1186/s12879-024-09839-3
Torimiro JNE, Duri K, Goumkwa NM, et al. Toward the elimination of hepatitis B: networking to promote the prevention of vertical transmission of hepatitis B virus through population-based interventions and multidisciplinary groups in Africa. Front Public Health 2024;12:1283350. DOI: https://doi.org/10.3389/fpubh.2024.1283350
Njoya O, Essi MJ, Ongolo BB, Obama MT. Connaissances perceptions et pratiques des femmes enceintes vis-a-vis de l’hépatite virale B en milieu urbain au Cameroun [Knowledge, perceptions, and practices of pregnant women regarding viral hepatitis B in an urban setting in Cameroon]. Health Sci Dis 2013;14:1-4.
Gebrecherkos T, Girmay G, Lemma M, Negash M. Knowledge, Attitude, and Practice towards Hepatitis B Virus among Pregnant Women Attending Antenatal Care at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. Int J Hepatol 2020;2020:5617603. DOI: https://doi.org/10.1155/2020/5617603
Institut National de la Statistique, des Études Économiques et Démographiques (INSEED). Enquête Démographique et de Santé à Indicateurs Multiples 2014-2015 [Demographic and Health Survey with Multiple Indicators 2014-2015].
Available from: https://microdata.worldbank.org/index.php/catalog/2668
Shimakawa Y, Veillon P, Birguel J, et al. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study. Lancet Glob Health 2022;10:e521‑9. DOI: https://doi.org/10.1016/S2214-109X(22)00026-2
Coalition for Global Hepatitis Elimination (CGHE), Centers for Disease Control and Prevention (CDC), World Health Organization Headquarters & Regional Office for Africa. Introduction of Hepatitis B Birth Dose Vaccination in Africa: A Toolkit for National Immunization Technical Advisory Groups [Internet]. 2024. Available from: https://www.globalhep.org/tools-resources/introduction-hepatitis-b-birth-dose-vaccination-africa-toolkit-national
Supporting Agencies
This study was managed and funded by the MAGIS Foundation within the framework of the project “For a Resilient and Quality Health System in the Land of Toumaï – SiSaTou AID 12590/09/8 SiSaTou”, and by Regione Veneto CS2023B and the RogerVax Association.How to Cite
Prevalence of hepatitis B virus among pregnant women in the southern district of N’Djamena and strategies to prevent mother-to-child transmission. (2025). Sahelian Journal of Responsible One Health, 1(2). https://doi.org/10.4081/sjroh.2025.565
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.